{"id":"https://openalex.org/W2602283374","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.2039","title":"Phase I study of vorinostat combined with isotretinoin and temozolomide in adults with recurrent malignant gliomas.","display_name":"Phase I study of vorinostat combined with isotretinoin and temozolomide in adults with recurrent malignant gliomas.","publication_year":2015,"publication_date":"2015-05-20","ids":{"openalex":"https://openalex.org/W2602283374","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.2039","mag":"2602283374"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2015.33.15_suppl.2039","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.2039","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.2039","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005282702","display_name":"Marta Pe\u00f1as-Prado","orcid":"https://orcid.org/0000-0002-0860-3805","observed_orcids":["https://orcid.org/0000-0002-0860-3805"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marta Penas-Prado","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005194857","display_name":"Kenneth R. Hess","orcid":"https://orcid.org/0000-0003-1377-6070","observed_orcids":["https://orcid.org/0000-0003-1377-6070"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth R. Hess","raw_affiliation_strings":["Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113917859","display_name":"Victor A. Levin","orcid":"https://orcid.org/0000-0003-3909-2101","observed_orcids":["https://orcid.org/0000-0003-3909-2101"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I4210119922","display_name":"Kaiser Permanente Redwood City Medical Center","ror":"https://ror.org/02bz7vk34","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210119922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victor A. Levin","raw_affiliation_strings":["Kaiser Permanente Redwood City Hosp, Greenbrae, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaiser Permanente Redwood City Hosp, Greenbrae, CA","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I4210119922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104124631","display_name":"John Frederick De Groot","orcid":"https://orcid.org/0000-0003-1454-6461","observed_orcids":["https://orcid.org/0000-0003-1454-6461"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Frederick De Groot","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047608444","display_name":"Howard Colman","orcid":"https://orcid.org/0000-0002-4027-7317","observed_orcids":["https://orcid.org/0000-0002-4027-7317"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard Colman","raw_affiliation_strings":["Hunstman Cancer Inst  Univ of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hunstman Cancer Inst  Univ of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110346854","display_name":"Morris D. Groves","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Morris D. Groves","raw_affiliation_strings":["Texas Onc/US Onc - Austin Brain Tumor Ctr, Austin, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Onc/US Onc - Austin Brain Tumor Ctr, Austin, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106083527","display_name":"Charles A. Conrad","orcid":"https://orcid.org/0000-0001-5178-8465","observed_orcids":["https://orcid.org/0000-0001-5178-8465"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles A. Conrad","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062153042","display_name":"Monica Elena Loghin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monica Elena Loghin","raw_affiliation_strings":["Neuro-Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuro-Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040657587","display_name":"Kathy Hunter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathy Hunter","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064627876","display_name":"Mark R. Gilbert","orcid":"https://orcid.org/0000-0003-2556-9722","observed_orcids":["https://orcid.org/0000-0003-2556-9722"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark R. Gilbert","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111550344","display_name":"W.K. Alfred Yung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. K. Alfred Yung","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037535298","display_name":"Vinay K. Puduvalli","orcid":"https://orcid.org/0000-0001-8396-9500","observed_orcids":["https://orcid.org/0000-0001-8396-9500"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vinay K. Puduvalli","raw_affiliation_strings":["Ohio State University Comprehensive Cancer Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ohio State University Comprehensive Cancer Center, Columbus, OH","institution_ids":["https://openalex.org/I2799885155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"15_suppl","first_page":"2039","last_page":"2039"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vorinostat","display_name":"vorinostat","score":0.9990000128746033},{"id":"https://openalex.org/keywords/isotretinoin","display_name":"isotretinoin","score":0.9750000238418579},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/recurrent-malignant-glioma","display_name":"recurrent malignant glioma","score":0.8700000047683716},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9559999704360962},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9570000171661377},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9190000295639038},{"id":"https://openalex.org/keywords/dose-dense-chemotherapy","display_name":"dose-dense chemotherapy","score":0.8090000152587891},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8149999976158142},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9419999718666077},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7450000047683716},{"id":"https://openalex.org/keywords/anaplastic-glioma","display_name":"anaplastic glioma","score":0.7250000238418579},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.722000002861023},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.7749999761581421},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9110000133514404},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9909999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9273285865783691},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.6619335412979126},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6262041330337524},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6069915294647217},{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.5646967887878418},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.5501081943511963},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5017287731170654},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.500521183013916},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4649575650691986},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4482472538948059},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.39167970418930054},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3808992803096771},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.10862088203430176},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.09859976172447205},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.08025243878364563},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2015.33.15_suppl.2039","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.2039","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.2039","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2590790266","https://openalex.org/W2609068367","https://openalex.org/W2268389957","https://openalex.org/W2781261700","https://openalex.org/W2600771186","https://openalex.org/W2783692774","https://openalex.org/W2604030659","https://openalex.org/W2761274815","https://openalex.org/W2111013340","https://openalex.org/W2108985372"],"abstract_inverted_index":{"2039":[0],"Background:":[1],"Vorinostat":[2],"(Vor),":[3],"a":[4,69,79,121,178,284],"histone":[5],"deacetylase":[6],"inhibitor,":[7],"has":[8],"shown":[9],"preliminary":[10,150],"activity":[11,153],"in":[12,41,137,154,197,241,248,283,291],"recurrent":[13,45,89,155],"GBM.":[14,261],"Preclinical":[15],"studies":[16],"demonstrated":[17],"that":[18,31,279],"Vor":[19,32,101,112,303,353],"can":[20],"overcome":[21,34],"resistance":[22,35],"to":[23,36,126,134,149,172,191,330,373],"isotretinoin":[24],"(cRA)":[25],"and":[26,38,211,220,227,264,271],"temozolomide":[27],"(TMZ).":[28],"We":[29,67],"hypothesized":[30],"could":[33],"cRA":[37,114,308,321,340,360],"cytotoxic":[39,54],"chemotherapy":[40],"the":[42,53,128,292],"treatment":[43],"of":[44,73,75,96,152,160,180,189,258,268],"gliomas.":[46,156],"Carboplatin":[47],"(CBP)":[48],"was":[49,119,143,238],"originally":[50],"selected":[51],"as":[52],"drug":[55,142,266],"since":[56],"eligible":[57],"patients":[58,162,252],"would":[59],"have":[60],"failed":[61],"prior":[62],"standard":[63],"TMZ":[64,147,190,273,365],"therapy.":[65],"Methods:":[66],"conducted":[68],"Phase":[70,84,288,374],"I":[71],"study":[72,290],"combinations":[74,267],"these":[76],"agents":[77],"preceding":[78],"proposed":[80],"adaptive":[81,286],"randomized":[82,287],"3-arm":[83],"II":[85,289,375],"study.":[86],"Adults":[87],"with":[88,277],"malignant":[90],"glioma":[91],"were":[92,168,183,274],"enrolled":[93,169],"into":[94],"one":[95],"3":[97,122,124,265],"arms.":[98],"Arm":[99,104,110,192,201,214,222,230,300,313,326,349],"1:":[100],"+":[102,107,113,115,123],"cRA,":[103,108,270],"2:":[105],"CBP":[106,316,346],"or":[109],"3:":[111],"CBP.":[116],"Dose":[117],"escalation":[118],"by":[120,145],"design":[125],"define":[127],"maximum":[129],"tolerated":[130,276],"dose":[131,331],"(MTD).":[132],"Due":[133],"excessive":[135],"toxicity":[136],"arms":[138],"containing":[139],"CBP,":[140],"this":[141],"replaced":[144],"dose-dense":[146,272],"due":[148],"evidence":[151],"Results:":[157],"A":[158],"total":[159,179],"55":[161],"(8":[163],"anaplastic":[164],"gliomas,":[165],"47":[166],"GBM)":[167],"from":[170],"11/2007":[171],"03/2012.":[173],"Among":[174],"52":[175],"evaluable":[176],"patients,":[177,243],"11":[181],"DLTs":[182],"seen,":[184],"but":[185],"none":[186],"after":[187],"introduction":[188],"3.":[193],"MTDs":[194],"are":[195],"summarized":[196],"Table.":[198],"Toxicities":[199],"included:":[200],"1":[202,301,320],"\u2013":[203,216,232],"neutropenia,":[204,217],"thrombocytopenia,":[205,233],"pulmonary":[206],"embolism,":[207],"elevated":[208],"AST":[209],"(DLT),":[210,219],"hypertriglyceridemia":[212],"(DLT);":[213,229],"2/CBP":[215,314],"thrombocytopenia":[218,225],"hypertriglyceridemia;":[221],"3A/CBP":[223,327],"-":[224],"(DLT)":[226],"hypokalemia":[228],"3B/TMZ":[231,350],"hypertriglyceridemia,":[234],"fatigue.":[235],"Best":[236],"response":[237],"stable":[239],"disease":[240],"26":[242],"for":[244],"\u2265":[245],"4":[246],"months":[247],"15":[249],"patients;":[250],"10":[251],"achieved":[253],"6-month":[254],"progression-free":[255],"survival;":[256],"7":[257],"whom":[259],"had":[260],"Conclusions:":[262],"Two":[263],"Vor,":[269],"well":[275],"MTD":[278,299],"will":[280],"be":[281],"used":[282],"multicenter":[285],"near":[293],"future.":[294],"Clinical":[295],"trial":[296],"information:":[297],"NCT00555399.":[298],"(n=14)":[302],"400":[304],"mg/day,":[305,355],"D":[306,311,319,324,356,363,368],"1-14":[307],"100":[309,322,341,361],"mg/m2/day,":[310,323,362,367],"1-21":[312,325,364],"(n=12)*":[315],"AUC":[317,347],"5,":[318],"(n=19)*":[328],"De-escalation":[329],"level":[332],"-3":[333],"(Vor":[334],"300":[335],"mg/day":[336],"x":[337,343],"14":[338],"days;":[339,345],"mg/m2/day":[342],"21":[344],"4)":[348],"(n":[351],"=10)":[352],"500":[354],"1-7":[357,369],"&":[358],"15-21":[359],"150":[366],"&15-21":[370],"*Not":[371],"going":[372]},"counts_by_year":[{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-07T00:00:00"}